Skip to main content
HIKMA Pharmaceuticals PLC logo

HIKMA Pharmaceuticals PLC — Investor Relations & Filings

Ticker · HIK ISIN · GB00B0LCW083 LEI · 549300BNS685UXH4JI75 IL Manufacturing
Filings indexed 5 across all filing types
Latest filing 2026-03-18 Annual Report (ESEF)
Country GB United Kingdom
Listing IL HIK

About HIKMA Pharmaceuticals PLC

https://www.hikma.com/home/

Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad portfolio of pharmaceutical products. The company's offerings include a wide range of generic, branded, specialty, and in-licensed medicines. It is a significant supplier of generic injectable products to hospitals and also provides oral generics and other specialty medications. With a focus on producing high-quality medicines, Hikma aims to make its products accessible to patients and healthcare providers across its key markets in North America, Europe, and the Middle East & North Africa (MENA) region.

Recent filings

Filing Released Lang Actions
2025 Annual Report and Accounts
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-03-18 English
2024 Annual Report and Accounts
Annual Report (ESEF) Classification · 100% confidence FY 2024
2025-03-19 English
2023 Annual Report and Accounts
Annual Report (ESEF) Classification · 100% confidence FY 2023
2024-03-22 English
Annual Report and Accounts
Annual Report (ESEF) Classification · 100% confidence FY 2022
2023-03-16 English
2021 Annual Report and Financial Statements-T01
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.